Unclear Diagnoses in Patients with Metastatic Disease

Video Library - Interview with the Innovators
Ralph V. Boccia, MD, FACP
Dr. Boccia addresses the problem of unclear diagnoses affecting approximately 15% of newly diagnosed patients with metastatic disease each year and the importance of an accurate diagnosis of tumor type in selecting the proper site-specific therapies.
Related Items
The bioT3 platform
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
Clinical Validation of CancerTYPE ID
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
CancerTYPE ID in the Clinic
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
CancerTREATMENT NGS+ in the Clinic
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
Managing Costs in Oncology Care
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
Last modified: April 14, 2015
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • National Association of Specialty Pharmacy
  • Lynx CME